Advertisement

The Scientist

» clinical trials and evolution

Most Recent

image: Clinical Trial Transparency in Europe?

Clinical Trial Transparency in Europe?

By | March 28, 2013

The regulatory body that licenses drugs for use in the European Union is devising a policy that will require the publication of some clinical trial data.

1 Comment

image: The Upside of Suicide

The Upside of Suicide

By | March 20, 2013

Researchers show that a bacterium’s self-sacrifice can benefit its community, even when the members are not strongly related.

4 Comments

image: Opinion:  Unconventional Standards

Opinion: Unconventional Standards

By | March 13, 2013

Tailoring ethical oversight to participant-led research

2 Comments

image: Sequencing the Underdogs

Sequencing the Underdogs

By | March 8, 2013

Transcriptome studies reveal new insights about unusual animals whose genomes have not been sequenced.

2 Comments

image: Algae Get Help to Go to Extremes

Algae Get Help to Go to Extremes

By | March 7, 2013

A red alga appears to have adapted to extremely hot, acidic environments by collecting genes from bacteria and archaea.

0 Comments

image: FDA Reform to Boost US Economy?

FDA Reform to Boost US Economy?

By | March 5, 2013

Two experts propose replacing Phase 3 trials with smaller, faster alternatives and post-market surveillance to invigorate the pharmaceutical industry.

0 Comments

image: Networking Medicine

Networking Medicine

By | March 2, 2013

Although fully organized patient-run trials are still few and far between, patients are taking a more active role in clinical research.

0 Comments

image: Speaking of Science

Speaking of Science

By | March 1, 2013

March 2013's selection of notable quotes

0 Comments

image: Do-It-Yourself Medicine

Do-It-Yourself Medicine

By | March 1, 2013

Patients are sidestepping clinical research and using themselves as guinea pigs to test new treatments for fatal diseases. Will they hurt themselves, or science?

9 Comments

image: Antibody-Drug Combo Approved

Antibody-Drug Combo Approved

By | February 25, 2013

The FDA approves an antibody-drug conjugate that effectively treats a certain type of advanced breast cancer with fewer side effects than previous drugs.

0 Comments

Advertisement

Popular Now

  1. The Sum of Our Parts
    Features The Sum of Our Parts

    Putting the microbiome front and center in health care, in preventive strategies, and in health-risk assessments could stem the epidemic of noncommunicable diseases.

  2. Most Earth-like Planet Found
  3. Ancient Viruses as Gene Therapy Vectors
  4. Judge Decides on GM Rice Retraction
Advertisement
PDA
PDA
Advertisement